• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ALA
Click for more information
5.56% 19.0¢

AROVELLA THERAPEUTICS LIMITED - News & Media

Market Cap $168.2M  ! watchlist Created with Sketch. Add to my watchlist

Arovella Therapeutics Limited is a biotechnology company. The Company is focused on... Arovella Therapeutics Limited is a biotechnology company. The Company is focused on developing its invariant natural killer T (iNKT) cell therapy platform from Imperial College London to treat blood cancers and solid tumors. The Company's lead product is ALA-101. ALA-101 is being developed as an allogeneic cell therapy, which means it can be given from a healthy donor to a patient. ALA-101 is a next-generation CAR-iNKT cell therapy that targets CD19+ B cell lymphomas and leukemias. ALA-101 consists of CAR19-iNKT cells that have been modified to produce a Chimeric Antigen Receptor (CAR) that targets CD19. CD19 is an antigen found on the surface of numerous cancer types. The Company is also engaged in expanding solid tumor treatment through its CLDN18.2-targeting technology licensed from Sparx Group. Its iNKT cells also contain an invariant T cell receptor (iTCR) that targets alpha-galactosylceramide (a-GalCer) bound CD1d, another antigen found on the surface of several cancer types.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

No News & Media currently available.

(20min delay)
Last
19.0¢ 		Change
0.010(5.56%) 		Mkt cap ! $168.2M
Open High Low Value Volume
18.5¢ 19.0¢ 18.0¢ $72.79K 390.7K

Buyers (Bids)

No. Vol. Price($)
2 128108 18.5¢
 

Sellers (Offers)

Price($) Vol. No.
19.0¢ 16666 1
View Market Depth
Last trade - 13.44pm 22/11/2024 (20 minute delay) ?
Last
19.0¢ 		  Change
0.010 ( 2.70 %)
Open High Low Volume
18.5¢ 19.5¢ 18.5¢ 190058
Last updated 13.44pm 22/11/2024 ?
ALA (ASX) Chart

Top Stories

HotCopper Highlights: Your most watched stocks for Week 47, 2024

In this segment we’ll look at the top stocks HotCopper users have been watching, and discussing, through Week 47. Let’s get into it. 
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
Dale Gillham's weekly wrap: Sigma-Chemist Warehouse merger creates pharma powerhouse The $8.8 billion dollar merger between Sigma Healthcare and Chemist Warehouse is poised to reshape the Australian pharmacy landscape, consolidating power in the hands of two industry giants. But what does this mean for Australians @ greater access to cheaper medicines or the loss of small, commun...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.